Unveiling Drug Responses in Liver Spheroids: Multiplexing 3D Cell-Based Assays and Imaging in a Microwell Platform
In collaboration with Tecan and Promega. As presented at EuroTox, Ljubljana, 2023.
handylandDecember 31, 2023
A novel approach for label-free drug efficacy analyses of pancreatic cancer organoids using high-content imaging
In collaboration with Molecular Devices. As presented at MPS summit, Berlin, 2023.
A microwell platform to standardize human rectal organoid cultures for high-content imaging and phenotypic analyses
In collaboration with Molecular Devices. As presented at ELRIG Drug Discovery, London, 2022.
handylandOctober 26, 2022
High-content imaging and morphology analyses on standardized human rectal organoid arrays
In collaboration with Molecular Devices. As presented at SLAS Europe, Dublin 2022.
handylandOctober 5, 2022
Towards high-throughput modelling of inflammatory bowel disease using human intestinal organoids
In collaboration with Molecular Devices. As presented at ISSCR, San Francisco 2022.
handylandOctober 5, 2022
Assessing combination therapies in human pancreatic cancer organoids using a standardized screening workflow
As presented at ISSCR, San Francisco 2022
handylandOctober 5, 2022
An automated standardized screening workflow for assessing combination therapies in human pancreatic cancer organoids
As presented at ELRIG Drug Discovery, Liverpool 2021.
handylandOctober 5, 2022
Comparison of automated high-content image-based phenotypic screening models for drug discovery: from 2D cultures to 3D spheroids and organoids
As presented at Workshop Organoids in Cancer Research, Lausanne 2021
handylandOctober 5, 2022
